```html

Pseudomembranous Colitis: What You Need to Know

What is Pseudomembranous colitis?

Pseudomembranous colitis (PMC) is an inflammation of the colon caused by the over‑growth of Clostridioides difficile (formerly Clostridium difficile) bacteria after the normal gut flora have been disturbed. The infection produces toxins that damage the lining of the large intestine, leading to the formation of characteristic yellow‑white “pseudomembranes” – layers of inflammatory cells, fibrin, and necrotic tissue that can be seen during colonoscopy or on imaging.

Although many people think of PMC as a hospital‑acquired infection, it can also occur in community settings, especially after antibiotic use. The condition ranges from mild diarrhea to life‑threatening colitis with perforation or sepsis.

Common Causes

The primary trigger for PMC is disruption of the normal bacterial balance in the colon, most often from antibiotics. Other risk factors can predispose a person to develop the infection.

• Broad‑spectrum antibiotics – clindamycin, fluoroquinolones, cephalosporins, cloxacillin, and ampicillin are the most notorious.
• Hospitalization or long‑term care – close quarters and frequent antibiotic exposure increase risk.
• Proton‑pump inhibitors (PPIs) – reduce stomach acidity, allowing more spores to reach the colon.
• Advanced age – immune function and gut flora change with age.
• Immunosuppression – chemotherapy, HIV/AIDS, organ transplantation, or corticosteroid therapy.
• Recent gastrointestinal surgery – especially bowel resections.
• Previous C. difficile infection – recurrence is common (up to 20‑30%).
• Inflammatory bowel disease (IBD) – ulcerative colitis or Crohn’s disease can complicate the picture.
• Use of laxatives or antidiarrheal agents that alter motility and bacterial composition.
• Travel to regions with high C. difficile prevalence – especially hospitals abroad.

Associated Symptoms

Symptoms usually appear 2‑10 days after the inciting factor (most often an antibiotic). The classic presentation includes:

• Watery diarrhea (often ≥3 loose stools per day)
• Abdominal cramping or pain, usually in the lower abdomen
• Fever (≥38 °C/100.4 °F)
• Loss of appetite and nausea
• Fecal urgency or incontinence
• Sometimes blood or mucus in the stool (more common with severe disease)
• Dehydration signs – dry mouth, dizziness, reduced urine output
• Elevated white blood cell count (leukocytosis)
• Generalized weakness or fatigue

When to See a Doctor

Most cases of PMC can be managed effectively when identified early. Seek medical attention promptly if you experience any of the following:

• Diarrhea lasting longer than 3 days after starting an antibiotic
• Fever ≥38 °C (100.4 °F) together with diarrhea
• Severe abdominal pain or swelling
• Blood or pus in the stool
• Signs of dehydration (dry lips, dizziness, dark urine)
• Rapid heart rate (>100 bpm) or low blood pressure
• Recent hospitalization, especially if you have taken antibiotics or PPIs

Early evaluation reduces the risk of complications such as toxic megacolon, perforation, or sepsis.

Diagnosis

Because the symptoms overlap with many other gastrointestinal disorders, a structured diagnostic approach is essential.

1. Clinical History & Physical Exam

Doctors ask about recent antibiotic use, hospital stays, medication list, and underlying illnesses. A focused abdominal exam checks for tenderness, distension, or guarding.

2. Laboratory Tests

• Stool toxin assay – rapid enzyme immunoassay (EIA) for C. difficile toxins A and B; highly specific.
• Polymerase chain reaction (PCR) – detects toxin‑producing genes; very sensitive, often used together with toxin assay.
• Complete blood count (CBC) – looks for leukocytosis.
• Serum electrolytes, creatinine, and BUN – assess dehydration and renal function.
• Albumin – a low level may indicate severe disease.

3. Imaging

• Abdominal X‑ray – may reveal colonic distension, “thumbprinting,” or signs of toxic megacolon.
• CT scan of the abdomen/pelvis – provides detailed view of wall thickening, pericolonic fat stranding, and complications.

4. Endoscopy (Colonoscopy or Flexible Sigmoidoscopy)

Used when diagnosis is uncertain or if severe disease is suspected. Visualizes the classic yellow‑white pseudomembranes adherent to inflamed mucosa. Biopsies can rule out other causes (e.g., IBD).

Treatment Options

Therapy aims to (1) halt toxin production, (2) restore normal gut flora, and (3) prevent complications.

1. Discontinue the inciting antibiotic

If possible, stop the offending drug; the body often clears the infection faster.

2. First‑line antimicrobial therapy

• Vancomycin 125 mg orally four times daily for 10 days – remains the preferred agent for initial episodes.
• Fidaxomicin 200 mg orally twice daily for 10 days – comparable efficacy with lower recurrence rates.

Both medications act locally in the colon and have minimal systemic absorption.

3. Second‑line / Severe disease

• High‑dose oral vancomycin (500 mg four times daily) plus IV metronidazole 500 mg every 8 h.
• Consider fecal microbiota transplantation (FMT) for multiple recurrences (≥3 episodes) or when standard therapy fails.

4. Supportive care

• Intravenous fluids to correct dehydration and electrolyte imbalances.
• Antipyretics (acetaminophen) for fever.
• Stop antidiarrheal agents (e.g., loperamide) – they may trap toxin‑producing bacteria.
• Probiotics – evidence is mixed; Lactobacillus rhamnosus GG may help prevent recurrence, but should not replace antibiotics.

5. Home care after discharge

• Complete the full antibiotic course, even if symptoms improve.
• Maintain good hydration – water, oral rehydration solutions, clear broths.
• Follow a low‑fiber, bland diet (e.g., bananas, rice, applesauce, toast) until diarrhea resolves.
• Wash hands thoroughly with soap and water after bathroom use; alcohol‑based sanitizers are less effective against C. difficile spores.

Prevention Tips

Because PMC is largely preventable, these strategies can dramatically reduce risk:

• Use antibiotics only when prescribed and complete the exact course.
• Ask your clinician if a narrower‑spectrum antibiotic could be chosen instead of broad‑spectrum agents.
• Limit the use of PPIs and H2 blockers; discuss alternatives with your doctor.
• Practice diligent hand‑washing with soap and water, especially in healthcare settings.
• Clean household surfaces with sporicidal agents (e.g., bleach 1:10) if someone has active infection.
• Consider probiotic supplementation during and shortly after a course of high‑risk antibiotics (consult a healthcare professional first).
• Stay up to date on infection‑control policies if you work in a hospital, nursing home, or daycare.
• For patients with recurrent PMC, discuss long‑term low‑dose vancomycin or tapered regimens with your gastroenterologist.

Emergency Warning Signs

Key Take‑aways

Pseudomembranous colitis is a toxin‑mediated inflammation of the colon most commonly triggered by antibiotic‑induced disruption of normal gut bacteria. Prompt recognition, appropriate testing, and targeted antimicrobial therapy (vancomycin or fidaxomicin) are the cornerstones of treatment. Hydration, cessation of the offending drug, and infection‑control measures are critical to prevent spread and recurrence. When severe symptoms or complications arise, urgent medical care can be lifesaving.

References:

• Mayo Clinic. “Clostridium difficile (C. diff) infection.” 2023. link
• CDC. “Antibiotic Use and C. difficile.” 2022. link
• NIH National Institute of Diabetes & Digestive & Kidney Diseases. “C. difficile (Clostridioides difficile) Infection.” 2024.
• Cleveland Clinic. “Pseudomembranous Colitis.” 2023.
• World Health Organization. “Guidelines on the prevention and control of Clostridioides difficile infection.” 2022.

```